Usability and utility of the CONSORT calculator for FSH starting doses: a prospective observational study.

This prospective, multicentre, observational study assessed usability and utility (co-primary endpoints) of the consistency in r-hFSH starting doses for individualized treatment (CONSORT) calculator in French routine clinical practice. Physicians first planned their recombinant human follicle-stimulating hormone (r-hFSH) starting dose. The CONSORT calculator was then used to recommend a starting dose.

Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa.

In this randomized, controlled, open-label, phase IV study, ovarian response after a follitropin alfa starting dose determined by the CONSORT calculator was compared with a standard dose (150 IU). Normo-ovulatory women (aged 18-34 years) eligible for assisted reproductive techniques were recruited (23 centres: nine European countries and Chile); 200 women were randomized (CONSORT [n = 96]; standard dosing [n = 104]). Significantly lower mean daily (121.

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study.

The CONSORT dosing algorithm individualizes recombinant human FSH (r-hFSH) doses for assisted reproduction technologies, assigning 37.5 IU increments according to patient characteristics: basal FSH, body mass index, age and antral follicle count. A prospective, uncontrolled, international, 18-centre, pilot study of normo-ovulatory women aged 18-34 years inclusive undergoing a long agonist treatment protocol was performed.

[Teratozoospermia, myth or reality? A 10-years retrospective study on 101404 consecutive sperm samples].

Objectives: Several studies have reported a time-related decline in semen quality. In this context, 101,404 spermograms-spermocytograms performed in a single andrology laboratory from January 2000 to December 2009 were investigated retrospectively. Variations of sperm parameters were analyzed over the years.

Ovarian hyperstimulation syndrome prevention strategies: individualizing gonadotropin dose.

The choice of the gonadotropin starting dose is an important parameter to prevent the onset of ovarian hyperstimulation syndrome (OHSS). The vast majority of studies available propose decreasing the gonadotropin starting dose, but conflicting results confirm that simply reducing the dose is not sufficient to prevent OHSS. True and dependable individualization of the gonadotropin starting dose is not yet possible.

The antral follicle count: practical recommendations for better standardization.

Objective: To provide recommendations for the standardized use of the Antral follicle count (AFC) which is used to predict ovarian response to gonadotrophin stimulation during assisted reproductive technology treatment. However, the nature of the follicles that are visualized by ultrasound and the competence of the oocytes held within are largely unknown. In addition, there is considerable variability in the clinical definitions and technical methods used to count and measure antral follicles in both published studies and clinical practice.

Women's views on Friendly IVF: a qualitative preliminary study.

Objective: To study in the French Context women's experiences with a low-stimulation regimen of in vitro fertilisation (Friendly IVF) and to compare them with those of women undergoing standard IVF (S-IVF).

Population And Methods: Two assisted reproduction technology centers participated in this preliminary study. Patients'views were explored qualitatively.

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study.

The CONSORT dosing algorithm individualizes recombinant human FSH (r-hFSH) doses for assisted reproduction technologies, assigning 37.5 IU increments according to patient characteristics: basal FSH, body mass index, age and antral follicle count. A prospective, uncontrolled, international, 18-centre, pilot study of normo-ovulatory women aged 18-34 years inclusive undergoing a long agonist treatment protocol was performed.

Psychological assessment of mothers and their assisted reproduction triplets at age 3 years.

The aim of this study was to examine the psychological well-being of mothers and the psychological development of their 3-year-old triplet children conceived by in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). Comparisons were carried out between a sample of 10 families with IVF/ICSI triplets and matched groups of 15 families with IVF/ICSI twins and 30 families with IVF/ICSI singletons. The families were recruited from Follow-Up, a national organization in France that was established to study children conceived by assisted reproduction.

Pregnancy after in vitro fertilization-intracytoplasmic sperm injection obtained with a modified natural cycle in a BRCA1 mutation carrier.

Objective: To report a successful pregnancy after a semi-natural IVF cycle for a BRCA1 gene mutation carrier.

Design: Case report.

Setting: University hospital.

Parenting and the psychological development of a representative sample of triplets conceived by assisted reproduction.

Background: The aim of the study was to examine the quality of parenting and the psychological development of three-year-old children in IVF/ICSI families with triplets.

Methods: Comparisons were carried out between a representative sample of 10 families with triplets and matched groups of 15 families with twins and 30 families with singletons. The families were recruited from Follow-Up, a national organization in France that was established to study children conceived by assisted reproduction.

Artificial versus stimulated cycles for endometrial preparation prior to frozen-thawed embryo transfer.

The objective of this study was to compare the implantation rate, pregnancy rate and endometrial thickness of frozen-thawed embryo transfers using endometrial preparation with either an artificial cycle or stimulated cycle. This was a prospective randomized trial at a single academic IVF centre. Seventy-seven patients undergoing artificial cycles received oral oestradiol; patients with endometrium < 7 mm on day 9-10 were switched to vaginal oestradiol.

Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours.

Background: Conservative surgery is currently proposed for young patients with borderline ovarian tumours (BOT). For those experiencing infertility, the question of medically assisted procreation is raised. We have evaluated in vitro the proliferation of cultured BOT cells in response to FSH or estradiol (E(2)).

[Ovulation induction].

Ovulation induction, indicated in anovulatory women, is nowadays a major treatment in any cause of infertility. Ovulation induction can be designed to obtained one or two follicles or to obtain a controlled ovarian hyperstimulation. Mild stimulations are used for anovulatory patients or patient with dysovulation, or for intrauterine insemination.

Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial.

Background: This study was designed to assess whether the use of ganirelix in women undergoing stimulated IUI could prevent the occurrence of premature LH rises and luteinization (LH+progesterone rises).

Methods: Women of infertile couples, diagnosed with unexplained or male factor infertility, were randomized to receive either ganirelix (n=103) or placebo (n=100) in a double-blind design. All women were treated with an individualized, low-dose rFSH regimen started on day 2-3 of cycle.

[Suspension of ART coverage: results of a survey in France].

The objective of the study was to investigate the criteria of patient selection and ART cycle cancellation in public and private fertility centers in France. A specific questionnaire was sent to 105 fertility centers. 81 centers have answered.

Do children born after assisted reproductive technology have a higher incidence of birth defects?

Recent studies seem to find a significant increase in the incidence of birth defects among children conceived with assisted reproductive technologies. Those data should lead to proper counseling of couples treated with these techniques.

[Oocyte donation: parents's secrets and lies].

Background: Since 1994, oocyte donation in France must be organized anonymously, in compliance with the bioethics law. The donation is free and any publicity to enrol donors is forbidden. In this system, the recipients are encouraged to incite a donor to visit the recipient's fertility unit.

Behavioral and cognitive development as well as family functioning of twins conceived by assisted reproduction: findings from a large population study.

Objective: To establish the nature and extent of difficulties in parenting and child development in families with twins conceived by assisted reproduction.

Design: Comparisons were carried out between a representative sample of 344 families with 2- to 5-year-old twins conceived by IVF/intracytoplasmic sperm injection (ICSI) and a matched comparison group of 344 families with singletons from IVF/ICSI. One twin was randomly selected for data analysis to avoid the bias associated with nonindependence of measures.

[Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].

Corpus luteum function seems to be impaired in IVF cycles with COH (Controlled Ovarian Hyperstimulation) and GnRH antagonist. Support of corpus luteum function remains mandatory after ovarian stimulation for IVF with GnRH antagonist cotreatment. GnRH antagonists do not have any impact on the luteal phase of IVF/ICSI cycles when hormonal support is given.